189 related articles for article (PubMed ID: 2462601)
1. T cell response to soluble cryptococcal antigens after recovery from cryptococcal infection.
Hoy JF; Murphy JW; Miller GG
J Infect Dis; 1989 Jan; 159(1):116-9. PubMed ID: 2462601
[No Abstract] [Full Text] [Related]
2. Cryptococcal meningitis; significance of positive antigen test on undiluted spinal fluid.
Salom IL
N Y State J Med; 1981 Aug; 81(9):1369-70. PubMed ID: 7022273
[No Abstract] [Full Text] [Related]
3. In vitro human lymphocyte responses to Cryptococcus neoformans. Evidence for primary and secondary responses in normals and infected subjects.
Miller GP; Puck J
J Immunol; 1984 Jul; 133(1):166-72. PubMed ID: 6373927
[TBL] [Abstract][Full Text] [Related]
4. Cell-mediated immunity in Cryptococcosis.
Graybill JR; Alford RH
Cell Immunol; 1974 Oct; 14(1):12-21. PubMed ID: 4619352
[No Abstract] [Full Text] [Related]
5. Induction of antigen-specific suppression by circulating Cryptococcus neoformans antigen.
Murphy JW; Cox RA
Clin Exp Immunol; 1988 Aug; 73(2):174-80. PubMed ID: 2460273
[TBL] [Abstract][Full Text] [Related]
6. Cryptococcus neoformans-specific oligoclonal immunoglobulins in cerebrospinal fluid in cryptococcal meningitis.
Porter KG; Sinnamon DG; Gillies RR
Lancet; 1977 Jun; 1(8024):1262. PubMed ID: 68362
[No Abstract] [Full Text] [Related]
7. Influence of cryptococcal antigens on cell-mediated immunity.
Murphy JW
Rev Infect Dis; 1988; 10 Suppl 2():S432-5. PubMed ID: 2973118
[TBL] [Abstract][Full Text] [Related]
8. Disseminated cryptococcosis in man: decreased lymphocyte transformation in response to Cryptococcus neoformans.
Diamond RD; Bennett JE
J Infect Dis; 1973 Jun; 127(6):694-7. PubMed ID: 4575001
[No Abstract] [Full Text] [Related]
9. Detection of antibodies to phospholipase B in patients infected with Cryptococcus neoformans by enzyme-linked immunosorbent assay (ELISA).
Santangelo RT; Chen SC; Sorrell TC; Wright LC
Med Mycol; 2005 Jun; 43(4):335-41. PubMed ID: 16110779
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary cryptococcosis: atypical results in the serum test for cryptococcal antigen.
Jenkins C; Breslin AB
Aust N Z J Med; 1982 Oct; 12(5):527-30. PubMed ID: 6758749
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cells and Cryptococcus neoformans.
Murphy JW
Adv Exp Med Biol; 1993; 335():269-75. PubMed ID: 8237604
[No Abstract] [Full Text] [Related]
12. Immunization of mice with stable, acapsular, yeast-like mutants of Cryptococcus neoformans.
Fromtling RA; Kaplan AM; Shadomy HJ
Sabouraudia; 1983 Jun; 21(2):113-9. PubMed ID: 6348975
[TBL] [Abstract][Full Text] [Related]
13. Immunogenic fractions of Cryptococcus neoformans.
Graybill JR; Straus DC; Nealon TJ; Hague M; Paque RE
Mycopathologia; 1982 Apr; 78(1):31-9. PubMed ID: 7048099
[TBL] [Abstract][Full Text] [Related]
14. [Fever of unknown origin and cryptococcal antigen].
Torroba Alvarez L; Fortún Abete J; Buzón Rueda L; Moreno Caparrós A
Med Clin (Barc); 1988 Oct; 91(13):514. PubMed ID: 3067009
[No Abstract] [Full Text] [Related]
15. False-negative cryptococcal antigen test.
Stamm AM; Polt SS
JAMA; 1980 Sep; 244(12):1359. PubMed ID: 6997519
[No Abstract] [Full Text] [Related]
16. Immunity in cryptococcosis: an overview.
Fromtling RA; Shadomy HJ
Mycopathologia; 1982 Mar; 77(3):183-90. PubMed ID: 7040977
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infection.
Schimpff SC; Bennett JE
J Allergy Clin Immunol; 1975 Jun; 55(6):430-41. PubMed ID: 1094054
[TBL] [Abstract][Full Text] [Related]
18. Opsonic activity of cerebrospinal fluid in experimental cryptococcal meningitis.
Hobbs MM; Perfect JR; Granger DL; Durack DT
Infect Immun; 1990 Jul; 58(7):2115-9. PubMed ID: 2194960
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen.
Murphy JW; Moorhead JW
J Immunol; 1982 Jan; 128(1):276-83. PubMed ID: 6172483
[TBL] [Abstract][Full Text] [Related]
20. Eosinophils elicit proliferation of naive and fungal-specific cells in vivo so enhancing a T helper type 1 cytokine profile in favour of a protective immune response against Cryptococcus neoformans infection.
Garro AP; Chiapello LS; Baronetti JL; Masih DT
Immunology; 2011 Oct; 134(2):198-213. PubMed ID: 21896014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
